Liposome-based drug and gene delivery systems have potential for significant roles in a
variety of therapeutic applications. Recently, liposomes have been used to entrap gas and …

Acoustically active liposomes (AAL), previously developed as ultrasound contrast agents,
contain small amounts of air. These AAL have potential to carry pharmaceutics and their …

Objectives : Our purpose was to quantitate and confirm specific echogenic immunoliposome
(ELIP) atheroma component enhancement in vivo. Background : Targeted ELIPs for …

Objectives : We sought to develop a new bioactive gas-delivery method by the use of echogenic
liposomes (ELIP) as the gas carrier. Background : Nitric oxide (NO) is a bioactive gas …

Background— Targeted echogenic immunoliposomes (ELIPs) for ultrasound enhancement
of atheroma components have been developed. To date, ELIP delivery has been intra-arterial…

BACKGROUND AND PURPOSE: Currently, the only FDA-approved therapy for acute ischemic
stroke is the administration of recombinant tissue plasminogen activator (tPA). Echogenic …

The objective of this study was to determine the physical basis of ultrasound (US) reflectivity
of echogenic lipid dispersions. These dispersions were made using a process previously …

Previously, passive cavitation imaging has been described in the context of continuous-wave
high-intensity focused ultrasound thermal ablation. However, the technique has potential …

The aim of this study was to characterize the frequency-dependent acoustic attenuation of
three phospholipid-shelled ultrasound contrast agents (UCAs): Definity, MicroMarker and …

Background— Ischemia-related neurological injury is a primary cause of stroke disability.
Studies have demonstrated that xenon (Xe) may have potential as an effective and nontoxic …